Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA

BACKGROUND: Metformin is a widely used oral hypoglycemizing agent recently proposed as potential anti-cancer drug. In this study we report the antiproliferative effect of metformin treatment in a high risk neuroblastoma cell model, focusing on possible effects associated to different levels of diffe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Costa, Delfina, Gigoni, Arianna, Würth, Roberto, Cancedda, Ranieri, Florio, Tullio, Pagano, Aldo
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2014
Ämnen:
Primary Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128937/
https://ncbi.nlm.nih.gov/pubmed/25120382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-14-59
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk